U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com

Read also:

• How do I write a character’s physical description without it feeling unnatural and clunky? I’m able to describe their hair and body relatively easily because my writing puts emphasis on small movements and fidgeting, but I can’t describe faces.
• Oil prices jump more than 3%, adding to last week's surge, as Israel strikes Iran energy facilities - CNBC
• LEGO Fortnite's Switch 2 Release Will Be Followed By A New Game Mode Next Week - Nintendo Life
• Why do I (45, male) feel like I'm crushing on a girl (19, female)?
• What would explain Trump blaming Ukraine for starting the war with Russia?
• Gen X, millennials are about three times more likely than their parents to be diagnosed with appendix cancer, study finds - CNN
• Where did Noah build the Ark? Was it in a desert or near water?
• How old is planet Earth? Is it 4.5 billion years old or 6,000 years old?
• Have you ever dealt with a Christian narcissist?
• I am 13 and I am planning to run away. What should I do to succeed?
• What should I expect after a BBL surgery?
• Why are Boomers so vehemently opposed to student loan forgiveness?
• Do any members of BTS have significant others in real life? If so, why do they choose not to discuss it publicly?